Logo image of HYPD

HYPERION DEFI INC (HYPD) Stock Overview

NASDAQ:HYPD - US30234E2037 - Common Stock

6.1 USD
-0.06 (-0.97%)
Last: 8/25/2025, 8:27:10 PM
6 USD
-0.1 (-1.64%)
After Hours: 8/25/2025, 8:27:10 PM

HYPD Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap34.71M
Shares5.69M
Float5.12M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-34.16
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10/amc
IPO01-25 2018-01-25
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


HYPD short term performance overview.The bars show the price performance of HYPD in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

HYPD long term performance overview.The bars show the price performance of HYPD in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of HYPD is 6.1 USD. In the past month the price decreased by -35.79%.

HYPERION DEFI INC / HYPD Daily stock chart

HYPD Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 43.05 658.10B
JNJ JOHNSON & JOHNSON 17.84 429.67B
NVO NOVO-NORDISK A/S-SPONS ADR 14.52 250.34B
AZN ASTRAZENECA PLC-SPONS ADR 17.94 246.98B
NVS NOVARTIS AG-SPONSORED ADR 14.13 242.06B
MRK MERCK & CO. INC. 11.08 213.09B
PFE PFIZER INC 7.42 142.93B
SNY SANOFI-ADR 11.37 122.26B
BMY BRISTOL-MYERS SQUIBB CO 7 95.95B
GSK GSK PLC-SPON ADR 8.83 79.91B
ZTS ZOETIS INC 24.95 68.78B
TAK TAKEDA PHARMACEUTIC-SP ADR 51.97 47.59B

About HYPD

Company Profile

HYPD logo image Eyenovia, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of ophthalmology products. The company is headquartered in New York City, New York and currently employs 13 full-time employees. The company went IPO on 2018-01-25. The company is focused on the commercialization of Mydcombi (tropicamide+phenylephrine ophthalmic spray) for mydriasis, as well as clobetasol propionate ophthalmic suspension 0.05% to reduce pain and inflammation following ocular surgery. Its product line includes Mydcombi, clobetasol propionate, and therapeutic programs, MicroPine and MicroLine. Mydcombi is its fixed combination formulation of tropicamide-phenylephrine for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. MicroPine is its topical therapy for the treatment of progressive myopia, a disease associated with pathologic axial elongation of the eye and sclero-retinal stretching. MicroLine is its investigational pharmacologic treatment for presbyopia, a non-preventable, age-related hardening of the lens.

Company Info

HYPERION DEFI INC

295 Madison Ave Ste 2400

New York City NEW YORK US

Employees: 13

HYPD Company Website

HYPD Investor Relations

Phone: 18137669539

HYPERION DEFI INC / HYPD FAQ

What is the stock price of HYPERION DEFI INC today?

The current stock price of HYPD is 6.1 USD. The price decreased by -0.97% in the last trading session.


What is the ticker symbol for HYPERION DEFI INC stock?

The exchange symbol of HYPERION DEFI INC is HYPD and it is listed on the Nasdaq exchange.


On which exchange is HYPD stock listed?

HYPD stock is listed on the Nasdaq exchange.


What is HYPERION DEFI INC worth?

HYPERION DEFI INC (HYPD) has a market capitalization of 34.71M USD. This makes HYPD a Nano Cap stock.


How many employees does HYPERION DEFI INC have?

HYPERION DEFI INC (HYPD) currently has 13 employees.


Is HYPERION DEFI INC (HYPD) expected to grow?

The Revenue of HYPERION DEFI INC (HYPD) is expected to grow by 400.98% in the next year. Check the estimates tab for more information on the HYPD EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy HYPERION DEFI INC (HYPD) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does HYPERION DEFI INC (HYPD) stock pay dividends?

HYPD does not pay a dividend.


When does HYPERION DEFI INC (HYPD) report earnings?

HYPERION DEFI INC (HYPD) will report earnings on 2025-11-10, after the market close.


What is the Price/Earnings (PE) ratio of HYPERION DEFI INC (HYPD)?

HYPERION DEFI INC (HYPD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-34.16).


What is the Short Interest ratio of HYPERION DEFI INC (HYPD) stock?

The outstanding short interest for HYPERION DEFI INC (HYPD) is 6.93% of its float. Check the ownership tab for more information on the HYPD short interest.


HYPD Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to HYPD.


Chartmill TA Rating
Chartmill Setup Rating

HYPD Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to HYPD. HYPD may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HYPD Financial Highlights

Over the last trailing twelve months HYPD reported a non-GAAP Earnings per Share(EPS) of -34.16. The EPS increased by 43.07% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -708.22%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%91.14%
Sales Q2Q%200%
EPS 1Y (TTM)43.07%
Revenue 1Y (TTM)781.58%

HYPD Forecast & Estimates

For the next year, analysts expect an EPS growth of 33.51% and a revenue growth 400.98% for HYPD


Analysts
Analysts47.5
Price TargetN/A
EPS Next Y33.51%
Revenue Next Year400.98%

HYPD Ownership

Ownership
Inst Owners13.16%
Ins Owners9.44%
Short Float %6.93%
Short Ratio0.4